Sign in

CIK 0000887359 · Large accelerated filer

Vericel Corp

Sign in to watch
Ticker
VCEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
MI
Entity type
operating
EIN
943096597
Phone
6175885555
Business address
25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
Former names
AASTROM BIOSCIENCES INC
  1. 4 Planned sale President and CEO sold 35,000 shares at an average $45.71 ($1,599,675)
  2. 4 Planned sale Director sold 7,000 shares at an average $45.94 ($321,580)
  3. 4 Planned sale President and CEO sold 35,000 shares at an average $51.48 ($1,801,625)
  4. 4 Planned sale Chief Legal Officer sold 15,000 shares at $52.18 ($782,700)
  5. 4 Planned sale Chief Financial Officer sold 5,000 shares at $50.00 ($250,000)
  6. 4 Planned sale Principal Accounting Officer sold 545 shares at $45.00 ($24,525)
  7. 4 Planned sale Chief Legal Officer sold 15,000 shares at an average $45.11 ($676,644)
  8. 4 Planned sale President and CEO sold 35,000 shares at an average $43.61 ($1,526,350)
  9. 4 Option exercise Director acquired 434 shares (option exercise)
  10. 4 Planned sale Chief Medical Officer sold 10,000 shares at $49.99 ($499,900)
  11. 4 Option exercise Chief Operating Officer acquired 5,195 shares (option exercise)
  12. 4 Planned sale President and CEO sold 35,000 shares at an average $48.76 ($1,706,600)
  13. 4 Option exercise Director acquired 3,200 shares (option exercise)
  14. 4 Option exercise Director acquired 3,200 shares (option exercise)
  15. 4 Option exercise Director acquired 3,200 shares (option exercise)
  16. 4 Option exercise Director acquired 3,200 shares (option exercise)
  17. 4 Option exercise Director acquired 3,200 shares (option exercise)
  18. 4 Option exercise Director acquired 3,200 shares (option exercise)
  19. 4 Option exercise Director acquired 3,200 shares (option exercise)
  20. 4 Option exercise President and CEO acquired 25,445 shares (option exercise)

Page 7 of 32 · 637 filings